In my experience as a cancer survivor, oncology discounts the importance of quality of life for cancer patients. According to the meta analysis linked below, mistletoe extract improved the quality of life of breast cancer patients.
Mistletoe extract may also be a cancer therapy aka kill cancer as well, unfortunately the research on this issue is vague.
What are the risks and benefits of mistletoe extract?
- Cancer Treatment: Some studies have suggested that mistletoe extract might have anti-cancer properties and could be used as a complementary therapy for cancer patients. It has been investigated for its potential to stimulate the immune system and improve the quality of life for cancer patients.
- Immunomodulatory Effects: Mistletoe extract contains compounds that may have immunomodulatory effects, which means they could influence the immune system. This has led to its exploration in conditions where immune system modulation may be beneficial.
- Cardiovascular Health: Some research suggests that mistletoe extract may have cardiovascular benefits, including potential blood pressure-lowering effects. However, more research is needed to confirm these findings.
- Toxicity: Mistletoe is known to be toxic, and ingestion of the plant or its berries can lead to adverse effects, including nausea, vomiting, diarrhea, and in severe cases, more serious toxic reactions.
- Drug Interactions: Mistletoe may interact with certain medications. For example, it could potentially enhance the effects of anticoagulant medications, leading to an increased risk of bleeding.
- Allergic Reactions: Some individuals may be allergic to mistletoe, and exposure can cause allergic reactions ranging from mild skin irritation to more severe symptoms.
- Pregnancy and Lactation: Mistletoe is generally not recommended for use during pregnancy or breastfeeding due to the lack of sufficient safety data. It may stimulate uterine contractions, posing a potential risk during pregnancy.
- Quality and Standardization: The quality of mistletoe extracts can vary, and there is a lack of standardization in preparation methods. This makes it challenging to ensure consistent and safe doses across different products.
Have you been diagnosed with breast cancer? What type? What stage? If you’d like to learn more about evidence-base non-conventional cancer therapies Let me know- David.PeopleBeatingCancer@gmail.com
- Cancer Survivor
- Cancer Coach
- Director PeopleBeatingCancer
“Breast cancer is the most common cancer type in women and quality of life an essential part of patients’ well-being. Although the treatment with mistletoe extracts is covered by multiple cancer guidelines and reviews, it is uncertain whether mistletoe extracts can improve the quality of life in breast cancer patients…
Nine RCTs and 7 NRSIs with 833 and 2831 participants, respectively, were included. The pre-post changes for the quality of life resulted in a pooled standardized mean difference for RCTs of SMD = 0.61 (95% CI 0.47-0.75; P < .0001) and for retrospective NRSIs of SMD = 0.46 (95% CI 0.10-0.82; P = .01). The risk of bias was low to high for the RCTs and serious for all NRSIs. The certainty of evidence was moderate for RCTs and very low for NRSIs.
Our results indicate a clinically relevant, medium-sized effect of mistletoe extracts on the quality of life in breast cancer patients which may be based on the immunomodulating effects of mistletoe extracts during chemotherapy. The limitations of evidence include the risk of bias which is mainly caused by the difficulty of blinding. Further RCTs and real-world evidence need to confirm this result, especially in the setting of neoadjuvant chemotherapy and in breast cancer survivors…
General Interpretation in Context of Other Evidence
Our analysis is, to our knowledge, the first meta-analysis to focus on the effect of ME on 1 cancer entity. We found a medium effect size of ME on the QoL of breast cancer patients with little heterogeneity between studies, compared to larger heterogeneity in an earlier study where different types of cancer were included in an overall meta-analysis.12…
Cognitive behavioral therapy (CBT) was reported to improve QoL with an SMD of 0.65 (95% CI 0.07-1.23) and a very low quality evidence in 1 study,54
whereas Getu et al estimated an effect of SMD = 0.39 (95% Ci 0.12-0.66) and concluded that CBT is effective in improving the QoL of breast cancer patients.
Compared to no therapy, yoga enhanced quality of life in breast cancer patients (SMD = 0.22 (95% CI 0.04-0.40)) with moderate-quality evidence.55
Mindfulness interventions improved quality of life in breast cancer patients by SMD = 0.21.56…
Possibly lower health standards in Eastern Europe, with less supportive care, might suggest that the effect size shown in this setting is the “ME only” effect, while this effect is diminished in Western Europe, where patients have access to other supportive therapies.
Apparently, real world settings do not seem to increase the effectiveness of ME with regards to overall QoL. This might have to do with the fact that such real-world documentations are often more susceptible to implementation difficulties regarding QoL data-collection procedures and unidentified influences compared to randomized studies.
Nonetheless, the NRSIs provide higher external validity by the real world setting and support the results deriving from RCTs that have inherently higher internal validity.”
“If you or someone you know has cancer, you may find yourself researching alternative and natural therapies to potentially improve treatment outcomes and enhance overall health and quality of life…
Why is mistletoe used to treat cancer?
Mistletoe contains several compounds that may have therapeutic potential, including:
- oligo- and polysaccharides,
- membrane lipids,
and more (2Trusted Source).
Although experts don’t yet fully understand how mistletoe’s potential anticancer properties work, it’s thought that the lectins concentrated in mistletoe may modulate the immune system, improving immune defenses and decreasing negative effects of cancer treatments (2Trusted Source)…
Viscotoxins are another type of active compound found in mistletoe. They are believed to have anticancer effects (1Trusted Source).
However, research suggests that complete mistletoe extract has more powerful anticancer effects than the isolated compounds found in mistletoe, implying that all compounds found in mistletoe, not just lectins and viscotoxins, contribute to these effects (1Trusted Source).
Studies show that mistletoe affects the immune system in a variety of ways that may be beneficial in treating cancer and reducing side effects of cancer treatment.
For example, in human studies, mistletoe extract administration has been shown to increase numbers of natural killer cells (NK cells), which are immune cells that fight cancer (7Trusted Source, 8Trusted Source, 9Trusted Source).
Mistletoe has also been shown to have anti-inflammatory effects, and some research suggests it may act as an antiangiogenesis agent. This means it may prevent the spread of cancer by stopping the growth of new blood vessels, cutting off fuel supply to tumors (4, 5Trusted Source).”